Clinical Trial Update: Effect of Ivabradine on Exercise Capacity After Heart Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of ivabradine on exercise capacity after heart transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy
• Transplanted Heart Complication

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Finn Gustafsson | Conditions: Cardiac Allograft Vasculopathy, Transplanted Heart Complication | Phase 4 | Status: UNKNOWN